<?xml version="1.0" encoding="UTF-8"?>
<p>Some observational studies correlate higher dietary or plasma levels of Ï‰-3s FAs with a lower risk of CVDs [
 <xref rid="B37-molecules-26-01002" ref-type="bibr">37</xref>,
 <xref rid="B39-molecules-26-01002" ref-type="bibr">39</xref>]. Looking at some clinical trials data from 1968 to 2019 [
 <xref rid="B9-molecules-26-01002" ref-type="bibr">9</xref>], EPA and DHA are reported to induce a slight but significant reduction in serum triglyceride levels, rate of cardiovascular mortality, and rate of coronary heart disease events [
 <xref rid="B9-molecules-26-01002" ref-type="bibr">9</xref>,
 <xref rid="B38-molecules-26-01002" ref-type="bibr">38</xref>], but results are often conflicting with the omega-3s sometimes not provoking any significant effects [
 <xref rid="B40-molecules-26-01002" ref-type="bibr">40</xref>,
 <xref rid="B41-molecules-26-01002" ref-type="bibr">41</xref>].
</p>
